The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

About Followers

Latest preprint reviews

  1. Providing a Safe, In-Person, Residential College Experience During the COVID-19 Pandemic

    1. Scott A. Travis
    2. Aaron A. Best
    3. Kristyn S. Bochniak
    4. Nicole D. Dunteman
    5. Jennifer Fellinger
    6. Peter D. Folkert
    7. Timothy Koberna
    8. Benjamin G. Kopek
    9. Brent P. Krueger
    10. Jeff Pestun
    11. Michael J. Pikaart
    12. Cindy Sabo
    13. Alex J. Schuitema

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Genetic variability associated with OAS1 expression in myeloid cells increases the risk of Alzheimer’s disease and severe COVID-19 outcomes

    1. Naciye Magusali
    2. Andrew C. Graham
    3. Thomas M. Piers
    4. Pantila Panichnantakul
    5. Umran Yaman
    6. Maryam Shoai
    7. Regina H. Reynolds
    8. Juan A. Botia
    9. Keeley J. Brookes
    10. Tamar Guetta-Baranes
    11. Eftychia Bellou
    12. Sevinc Bayram
    13. Dimitra Sokolova
    14. Mina Ryten
    15. Carlo Sala Frigerio
    16. Valentina Escott-Price
    17. Kevin Morgan
    18. Jennifer M. Pocock
    19. John Hardy
    20. Dervis A. Salih

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Assessing the extent and timing of chemosensory impairments during COVID-19 pandemic

    1. Cinzia Cecchetto
    2. Antonella Di Pizio
    3. Federica Genovese
    4. Orietta Calcinoni
    5. Alberto Macchi
    6. Andreas Dunkel
    7. Kathrin Ohla
    8. Sara Spinelli
    9. Michael C. Farruggia
    10. Paule V. Joseph
    11. Anna Menini
    12. Elena Cantone
    13. Caterina Dinnella
    14. Maria Paola Cecchini
    15. Anna D’Errico
    16. Carla Mucignat-Caretta
    17. Valentina Parma
    18. Michele Dibattista

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Factors preventing SARS-CoV-2 transmission during unintentional exposure in a GP practice: a cohort study of patient contacts; Germany, 2020

    1. T. Sonia Boender
    2. Jennifer K. Bender
    3. Angelika Krüger
    4. Kai Michaelis
    5. Udo Buchholz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. The role of childrens’ vaccination for COVID-19—Pareto-optimal allocations of vaccines

    1. Nir Gavish
    2. Guy Katriel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Relative expression of proinflammatory molecules in COVID‐19 patients who manifested disease severities

    1. Shireen Nigar
    2. SM Tanjil Shah
    3. Md Ali Ahasan Setu
    4. Sourav Dutta Dip
    5. Habiba Ibnat
    6. M. Touhidul Islam
    7. Selina Akter
    8. Iqbal Kabir Jahid
    9. M. Anwar Hossain

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave

    1. Jessica T. Davis
    2. Matteo Chinazzi
    3. Nicola Perra
    4. Kunpeng Mu
    5. Ana Pastore y Piontti
    6. Marco Ajelli
    7. Natalie E. Dean
    8. Corrado Gioannini
    9. Maria Litvinova
    10. Stefano Merler
    11. Luca Rossi
    12. Kaiyuan Sun
    13. Xinyue Xiong
    14. Ira M. Longini
    15. M. Elizabeth Halloran
    16. Cécile Viboud
    17. Alessandro Vespignani

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  8. Vaccination and herd immunity thresholds in heterogeneous populations

    1. Elamin H. Elbasha
    2. Abba B. Gumel

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Exploring epitope and functional diversity of anti-SARS-CoV2 antibodies using AI-based methods

    1. C. Dumet
    2. Y. Jullian
    3. A. Musnier
    4. Ph. Rivière
    5. N. Poirier
    6. H. Watier
    7. T. Bourquard
    8. A. Poupon

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  10. Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study

    1. Jonathon W. Senefeld
    2. Patrick W. Johnson
    3. Katie L. Kunze
    4. Evan M. Bloch
    5. Noud van Helmond
    6. Michael A. Golafshar
    7. Stephen A. Klassen
    8. Allan M. Klompas
    9. Matthew A. Sexton
    10. Juan C. Diaz Soto
    11. Brenda J. Grossman
    12. Aaron A. R. Tobian
    13. Ruchika Goel
    14. Chad C. Wiggins
    15. Katelyn A. Bruno
    16. Camille M. van Buskirk
    17. James R. Stubbs
    18. Jeffrey L. Winters
    19. Arturo Casadevall
    20. Nigel S. Paneth
    21. Beth H. Shaz
    22. Molly M. Petersen
    23. Bruce S. Sachais
    24. Matthew R. Buras
    25. Mikolaj A. Wieczorek
    26. Benjamin Russoniello
    27. Larry J. Dumont
    28. Sarah E. Baker
    29. Ralph R. Vassallo
    30. John R. A. Shepherd
    31. Pampee P. Young
    32. Nicole C. Verdun
    33. Peter Marks
    34. N. Rebecca Haley
    35. Robert F. Rea
    36. Louis Katz
    37. Vitaly Herasevich
    38. Dan A. Waxman
    39. Emily R. Whelan
    40. Aviv Bergman
    41. Andrew J. Clayburn
    42. Mary Kathryn Grabowski
    43. Kathryn F. Larson
    44. Juan G. Ripoll
    45. Kylie J. Andersen
    46. Matthew N. P. Vogt
    47. Joshua J. Dennis
    48. Riley J. Regimbal
    49. Philippe R. Bauer
    50. Janis E. Blair
    51. Zachary A. Buchholtz
    52. Michaela C. Pletsch
    53. Katherine Wright
    54. Joel T. Greenshields
    55. Michael J. Joyner
    56. R. Scott Wright
    57. Rickey E. Carter
    58. DeLisa Fairweather

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Newer Page 2199 of 2361 Older